nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—peripheral nervous system neoplasm—brain cancer	0.8	1	CtDrD
Isotretinoin—RXRA—ganglion—brain cancer	0.0043	0.123	CbGeAlD
Isotretinoin—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00214	0.0636	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00192	0.057	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00184	0.0547	CbGpPWpGaD
Isotretinoin—RXRA—telencephalon—brain cancer	0.00166	0.0474	CbGeAlD
Isotretinoin—RXRB—telencephalon—brain cancer	0.00137	0.0391	CbGeAlD
Isotretinoin—RXRG—pituitary gland—brain cancer	0.00119	0.0339	CbGeAlD
Isotretinoin—RXRG—medulla oblongata—brain cancer	0.00115	0.0327	CbGeAlD
Isotretinoin—RARA—telencephalon—brain cancer	0.00114	0.0327	CbGeAlD
Isotretinoin—RXRA—Pyruvate metabolism—BSG—brain cancer	0.00108	0.032	CbGpPWpGaD
Isotretinoin—RXRA—endocrine gland—brain cancer	0.00105	0.0299	CbGeAlD
Isotretinoin—RXRG—midbrain—brain cancer	0.00105	0.0299	CbGeAlD
Isotretinoin—RXRA—head—brain cancer	0.00103	0.0295	CbGeAlD
Isotretinoin—RXRG—spinal cord—brain cancer	0.00102	0.0292	CbGeAlD
Isotretinoin—RXRA—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00101	0.0299	CbGpPWpGaD
Isotretinoin—RARA—gonad—brain cancer	0.000954	0.0273	CbGeAlD
Isotretinoin—RXRA—central nervous system—brain cancer	0.000944	0.027	CbGeAlD
Isotretinoin—RARB—endocrine gland—brain cancer	0.000941	0.0269	CbGeAlD
Isotretinoin—RARA—pituitary gland—brain cancer	0.000931	0.0266	CbGeAlD
Isotretinoin—RARB—head—brain cancer	0.000928	0.0265	CbGeAlD
Isotretinoin—RXRG—endocrine gland—brain cancer	0.000919	0.0263	CbGeAlD
Isotretinoin—RXRG—head—brain cancer	0.000908	0.0259	CbGeAlD
Isotretinoin—RARG—Nuclear Receptors—ESR2—brain cancer	0.000906	0.0269	CbGpPWpGaD
Isotretinoin—RXRB—endocrine gland—brain cancer	0.000864	0.0247	CbGeAlD
Isotretinoin—RXRB—head—brain cancer	0.000853	0.0244	CbGeAlD
Isotretinoin—RXRG—Nuclear Receptors—ESR2—brain cancer	0.000829	0.0246	CbGpPWpGaD
Isotretinoin—RARB—cerebellum—brain cancer	0.000828	0.0237	CbGeAlD
Isotretinoin—RXRG—central nervous system—brain cancer	0.000828	0.0237	CbGeAlD
Isotretinoin—RARB—Nuclear Receptors—ESR2—brain cancer	0.000813	0.0241	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptors—ESR2—brain cancer	0.000779	0.0231	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptors—ESR2—brain cancer	0.000779	0.0231	CbGpPWpGaD
Isotretinoin—RXRB—central nervous system—brain cancer	0.000779	0.0222	CbGeAlD
Isotretinoin—RXRB—cerebellum—brain cancer	0.000761	0.0217	CbGeAlD
Isotretinoin—RARG—head—brain cancer	0.000757	0.0216	CbGeAlD
Isotretinoin—RXRA—brain—brain cancer	0.000749	0.0214	CbGeAlD
Isotretinoin—Tretinoin—CYP2C9—brain cancer	0.000723	1	CrCbGaD
Isotretinoin—RARA—endocrine gland—brain cancer	0.000721	0.0206	CbGeAlD
Isotretinoin—RARG—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000716	0.0213	CbGpPWpGaD
Isotretinoin—RARA—head—brain cancer	0.000712	0.0203	CbGeAlD
Isotretinoin—RARG—central nervous system—brain cancer	0.000691	0.0198	CbGeAlD
Isotretinoin—RARG—cerebellum—brain cancer	0.000676	0.0193	CbGeAlD
Isotretinoin—RARB—brain—brain cancer	0.000673	0.0192	CbGeAlD
Isotretinoin—RXRG—brain—brain cancer	0.000658	0.0188	CbGeAlD
Isotretinoin—RXRG—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000655	0.0195	CbGpPWpGaD
Isotretinoin—RXRA—Pyruvate metabolism and Citric Acid (TCA) cycle—BSG—brain cancer	0.000652	0.0194	CbGpPWpGaD
Isotretinoin—RARA—central nervous system—brain cancer	0.00065	0.0186	CbGeAlD
Isotretinoin—RARB—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000642	0.0191	CbGpPWpGaD
Isotretinoin—RARA—cerebellum—brain cancer	0.000635	0.0182	CbGeAlD
Isotretinoin—RXRB—brain—brain cancer	0.000618	0.0177	CbGeAlD
Isotretinoin—RARA—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000616	0.0183	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000616	0.0183	CbGpPWpGaD
Isotretinoin—RXRA—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000609	0.0181	CbGpPWpGaD
Isotretinoin—RARG—brain—brain cancer	0.000549	0.0157	CbGeAlD
Isotretinoin—RARA—brain—brain cancer	0.000516	0.0147	CbGeAlD
Isotretinoin—RXRG—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.000511	0.0152	CbGpPWpGaD
Isotretinoin—RXRA—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000494	0.0147	CbGpPWpGaD
Isotretinoin—RXRB—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.000481	0.0143	CbGpPWpGaD
Isotretinoin—RXRA—Orphan transporters—S100A10—brain cancer	0.000474	0.0141	CbGpPWpGaD
Isotretinoin—RXRA—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000459	0.0136	CbGpPWpGaD
Isotretinoin—RXRA—Transcription factor regulation in adipogenesis—IRS2—brain cancer	0.000408	0.0121	CbGpPWpGaD
Isotretinoin—RXRA—Nuclear Receptors—ESR2—brain cancer	0.000406	0.0121	CbGpPWpGaD
Isotretinoin—RXRA—PPAR Alpha Pathway—CDK4—brain cancer	0.000335	0.00995	CbGpPWpGaD
Isotretinoin—RXRG—a6b1 and a6b4 Integrin signaling—ERBB2—brain cancer	0.000322	0.00957	CbGpPWpGaD
Isotretinoin—RXRA—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000321	0.00953	CbGpPWpGaD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—ERBB2—brain cancer	0.000303	0.009	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000279	0.00829	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000268	0.00795	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000265	0.00786	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—CYP2C9—brain cancer	0.000262	0.00779	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000254	0.00753	CbGpPWpGaD
Isotretinoin—RXRA—The citric acid (TCA) cycle and respiratory electron transport—BSG—brain cancer	0.000253	0.00751	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.000251	0.00744	CbGpPWpGaD
Isotretinoin—RXRG—a6b1 and a6b4 Integrin signaling—EGFR—brain cancer	0.000223	0.00663	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000223	0.00663	CbGpPWpGaD
Isotretinoin—RXRA—PPAR Alpha Pathway—CCND1—brain cancer	0.000216	0.00643	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000214	0.00636	CbGpPWpGaD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—EGFR—brain cancer	0.00021	0.00624	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—IRS2—brain cancer	0.000201	0.00597	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—IRS2—brain cancer	0.000189	0.00562	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000183	0.00545	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.00018	0.00534	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000178	0.00528	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000176	0.00522	CbGpPWpGaD
Isotretinoin—RXRA—PPAR Alpha Pathway—MYC—brain cancer	0.000174	0.00515	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000172	0.00512	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.00017	0.00506	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000165	0.0049	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000158	0.0047	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—ERBB2—brain cancer	0.000158	0.00469	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000157	0.00467	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000151	0.00448	CbGpPWpGaD
Isotretinoin—Hypotension—Procarbazine—brain cancer	0.00015	0.00114	CcSEcCtD
Isotretinoin—Neuropathy peripheral—Temozolomide—brain cancer	0.000149	0.00114	CcSEcCtD
Isotretinoin—Stomatitis—Temozolomide—brain cancer	0.000148	0.00113	CcSEcCtD
Isotretinoin—Urinary tract infection—Temozolomide—brain cancer	0.000148	0.00113	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000146	0.00112	CcSEcCtD
Isotretinoin—Insomnia—Procarbazine—brain cancer	0.000145	0.00111	CcSEcCtD
Isotretinoin—Paraesthesia—Procarbazine—brain cancer	0.000144	0.0011	CcSEcCtD
Isotretinoin—Sinusitis—Temozolomide—brain cancer	0.000143	0.00109	CcSEcCtD
Isotretinoin—Somnolence—Procarbazine—brain cancer	0.000143	0.00109	CcSEcCtD
Isotretinoin—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000142	0.00109	CcSEcCtD
Isotretinoin—Haemoglobin—Carmustine—brain cancer	0.000142	0.00108	CcSEcCtD
Isotretinoin—Haemorrhage—Carmustine—brain cancer	0.000141	0.00108	CcSEcCtD
Isotretinoin—Ill-defined disorder—Hydroxyurea—brain cancer	0.000141	0.00108	CcSEcCtD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—CDK4—brain cancer	0.000141	0.00417	CbGpPWpGaD
Isotretinoin—Anaemia—Hydroxyurea—brain cancer	0.000141	0.00107	CcSEcCtD
Isotretinoin—Hallucination—Carmustine—brain cancer	0.000141	0.00107	CcSEcCtD
Isotretinoin—Hypoaesthesia—Carmustine—brain cancer	0.000141	0.00107	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000139	0.00414	CbGpPWpGaD
Isotretinoin—Decreased appetite—Procarbazine—brain cancer	0.000139	0.00106	CcSEcCtD
Isotretinoin—Oedema peripheral—Carmustine—brain cancer	0.000139	0.00106	CcSEcCtD
Isotretinoin—Fatigue—Procarbazine—brain cancer	0.000138	0.00106	CcSEcCtD
Isotretinoin—Haemoglobin—Temozolomide—brain cancer	0.000137	0.00105	CcSEcCtD
Isotretinoin—Malaise—Hydroxyurea—brain cancer	0.000137	0.00105	CcSEcCtD
Isotretinoin—Constipation—Procarbazine—brain cancer	0.000137	0.00105	CcSEcCtD
Isotretinoin—Pain—Procarbazine—brain cancer	0.000137	0.00105	CcSEcCtD
Isotretinoin—Haemorrhage—Temozolomide—brain cancer	0.000136	0.00104	CcSEcCtD
Isotretinoin—Hepatitis—Temozolomide—brain cancer	0.000136	0.00104	CcSEcCtD
Isotretinoin—Dysphagia—Etoposide—brain cancer	0.000136	0.00104	CcSEcCtD
Isotretinoin—Visual impairment—Carmustine—brain cancer	0.000136	0.00104	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000136	0.00404	CbGpPWpGaD
Isotretinoin—Hypoaesthesia—Temozolomide—brain cancer	0.000136	0.00104	CcSEcCtD
Isotretinoin—Hallucination—Temozolomide—brain cancer	0.000136	0.00104	CcSEcCtD
Isotretinoin—Pharyngitis—Temozolomide—brain cancer	0.000135	0.00103	CcSEcCtD
Isotretinoin—Urinary tract disorder—Temozolomide—brain cancer	0.000135	0.00103	CcSEcCtD
Isotretinoin—Oedema peripheral—Temozolomide—brain cancer	0.000134	0.00103	CcSEcCtD
Isotretinoin—Bronchospasm—Etoposide—brain cancer	0.000134	0.00102	CcSEcCtD
Isotretinoin—Urethral disorder—Temozolomide—brain cancer	0.000134	0.00102	CcSEcCtD
Isotretinoin—Sweating increased—Etoposide—brain cancer	0.000133	0.00101	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000132	0.00393	CbGpPWpGaD
Isotretinoin—Feeling abnormal—Procarbazine—brain cancer	0.000132	0.00101	CcSEcCtD
Isotretinoin—Eye disorder—Carmustine—brain cancer	0.000132	0.00101	CcSEcCtD
Isotretinoin—Convulsion—Hydroxyurea—brain cancer	0.000132	0.00101	CcSEcCtD
Isotretinoin—Visual impairment—Temozolomide—brain cancer	0.000132	0.001	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Procarbazine—brain cancer	0.000131	0.001	CcSEcCtD
Isotretinoin—Flushing—Carmustine—brain cancer	0.000131	0.001	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.00013	0.00387	CbGpPWpGaD
Isotretinoin—Erythema multiforme—Temozolomide—brain cancer	0.000129	0.000985	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000129	0.000982	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000128	0.0038	CbGpPWpGaD
Isotretinoin—Discomfort—Hydroxyurea—brain cancer	0.000128	0.000977	CcSEcCtD
Isotretinoin—Neutropenia—Etoposide—brain cancer	0.000128	0.000974	CcSEcCtD
Isotretinoin—Eye disorder—Temozolomide—brain cancer	0.000128	0.000974	CcSEcCtD
Isotretinoin—Urticaria—Procarbazine—brain cancer	0.000127	0.000973	CcSEcCtD
Isotretinoin—Tinnitus—Temozolomide—brain cancer	0.000127	0.000971	CcSEcCtD
Isotretinoin—Body temperature increased—Procarbazine—brain cancer	0.000127	0.000968	CcSEcCtD
Isotretinoin—Abdominal pain—Procarbazine—brain cancer	0.000127	0.000968	CcSEcCtD
Isotretinoin—Flushing—Temozolomide—brain cancer	0.000127	0.000967	CcSEcCtD
Isotretinoin—Arrhythmia—Carmustine—brain cancer	0.000126	0.000963	CcSEcCtD
Isotretinoin—Alopecia—Carmustine—brain cancer	0.000125	0.000953	CcSEcCtD
Isotretinoin—Oedema—Hydroxyurea—brain cancer	0.000124	0.000948	CcSEcCtD
Isotretinoin—Angiopathy—Temozolomide—brain cancer	0.000124	0.000945	CcSEcCtD
Isotretinoin—Mental disorder—Carmustine—brain cancer	0.000124	0.000945	CcSEcCtD
Isotretinoin—RARG—Generic Transcription Pathway—ESR2—brain cancer	0.000124	0.00367	CbGpPWpGaD
Isotretinoin—Infection—Hydroxyurea—brain cancer	0.000123	0.000941	CcSEcCtD
Isotretinoin—Erythema—Carmustine—brain cancer	0.000123	0.000939	CcSEcCtD
Isotretinoin—Malnutrition—Carmustine—brain cancer	0.000123	0.000939	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000123	0.00365	CbGpPWpGaD
Isotretinoin—Chills—Temozolomide—brain cancer	0.000122	0.000935	CcSEcCtD
Isotretinoin—Pneumonia—Etoposide—brain cancer	0.000122	0.000934	CcSEcCtD
Isotretinoin—Nervous system disorder—Hydroxyurea—brain cancer	0.000122	0.000929	CcSEcCtD
Isotretinoin—Infestation—Etoposide—brain cancer	0.000122	0.000929	CcSEcCtD
Isotretinoin—Infestation NOS—Etoposide—brain cancer	0.000122	0.000929	CcSEcCtD
Isotretinoin—Thrombocytopenia—Hydroxyurea—brain cancer	0.000122	0.000928	CcSEcCtD
Isotretinoin—RXRG—Adipogenesis—CTNNB1—brain cancer	0.000121	0.00358	CbGpPWpGaD
Isotretinoin—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000121	0.000921	CcSEcCtD
Isotretinoin—Alopecia—Temozolomide—brain cancer	0.000121	0.000921	CcSEcCtD
Isotretinoin—Skin disorder—Hydroxyurea—brain cancer	0.000121	0.00092	CcSEcCtD
Isotretinoin—Acute coronary syndrome—Etoposide—brain cancer	0.00012	0.000916	CcSEcCtD
Isotretinoin—Renal failure—Etoposide—brain cancer	0.00012	0.000913	CcSEcCtD
Isotretinoin—Mental disorder—Temozolomide—brain cancer	0.00012	0.000913	CcSEcCtD
Isotretinoin—Myocardial infarction—Etoposide—brain cancer	0.000119	0.00091	CcSEcCtD
Isotretinoin—Neuropathy peripheral—Etoposide—brain cancer	0.000119	0.00091	CcSEcCtD
Isotretinoin—Back pain—Carmustine—brain cancer	0.000119	0.000908	CcSEcCtD
Isotretinoin—Erythema—Temozolomide—brain cancer	0.000119	0.000907	CcSEcCtD
Isotretinoin—Malnutrition—Temozolomide—brain cancer	0.000119	0.000907	CcSEcCtD
Isotretinoin—Stomatitis—Etoposide—brain cancer	0.000119	0.000905	CcSEcCtD
Isotretinoin—Anorexia—Hydroxyurea—brain cancer	0.000118	0.000903	CcSEcCtD
Isotretinoin—Hypersensitivity—Procarbazine—brain cancer	0.000118	0.000902	CcSEcCtD
Isotretinoin—RARG—Generic Transcription Pathway—NOTCH2—brain cancer	0.000117	0.00348	CbGpPWpGaD
Isotretinoin—Vision blurred—Carmustine—brain cancer	0.000116	0.000885	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—S100A10—brain cancer	0.000116	0.00343	CbGpPWpGaD
Isotretinoin—Tremor—Carmustine—brain cancer	0.000115	0.000879	CcSEcCtD
Isotretinoin—Asthenia—Procarbazine—brain cancer	0.000115	0.000878	CcSEcCtD
Isotretinoin—Back pain—Temozolomide—brain cancer	0.000115	0.000877	CcSEcCtD
Isotretinoin—Anaemia—Carmustine—brain cancer	0.000114	0.000867	CcSEcCtD
Isotretinoin—Agranulocytosis—Etoposide—brain cancer	0.000114	0.000867	CcSEcCtD
Isotretinoin—RARA—Adipogenesis—CTNNB1—brain cancer	0.000113	0.00337	CbGpPWpGaD
Isotretinoin—Pruritus—Procarbazine—brain cancer	0.000113	0.000866	CcSEcCtD
Isotretinoin—RXRG—Generic Transcription Pathway—ESR2—brain cancer	0.000113	0.00336	CbGpPWpGaD
Isotretinoin—Agitation—Carmustine—brain cancer	0.000113	0.000863	CcSEcCtD
Isotretinoin—Vision blurred—Temozolomide—brain cancer	0.000112	0.000855	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000112	0.00331	CbGpPWpGaD
Isotretinoin—Tremor—Temozolomide—brain cancer	0.000111	0.00085	CcSEcCtD
Isotretinoin—RARB—Generic Transcription Pathway—ESR2—brain cancer	0.000111	0.00329	CbGpPWpGaD
Isotretinoin—Dyspnoea—Hydroxyurea—brain cancer	0.000111	0.000845	CcSEcCtD
Isotretinoin—Somnolence—Hydroxyurea—brain cancer	0.00011	0.000842	CcSEcCtD
Isotretinoin—Ill-defined disorder—Temozolomide—brain cancer	0.00011	0.000842	CcSEcCtD
Isotretinoin—Anaemia—Temozolomide—brain cancer	0.00011	0.000838	CcSEcCtD
Isotretinoin—Diarrhoea—Procarbazine—brain cancer	0.00011	0.000838	CcSEcCtD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—brain cancer	0.000109	0.00325	CbGpPWpGaD
Isotretinoin—Dyspepsia—Hydroxyurea—brain cancer	0.000109	0.000834	CcSEcCtD
Isotretinoin—Agitation—Temozolomide—brain cancer	0.000109	0.000834	CcSEcCtD
Isotretinoin—Hypoaesthesia—Etoposide—brain cancer	0.000109	0.00083	CcSEcCtD
Isotretinoin—Decreased appetite—Hydroxyurea—brain cancer	0.000108	0.000824	CcSEcCtD
Isotretinoin—Urinary tract disorder—Etoposide—brain cancer	0.000108	0.000823	CcSEcCtD
Isotretinoin—RXRG—Generic Transcription Pathway—NOTCH2—brain cancer	0.000107	0.00318	CbGpPWpGaD
Isotretinoin—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000107	0.000818	CcSEcCtD
Isotretinoin—Malaise—Temozolomide—brain cancer	0.000107	0.000818	CcSEcCtD
Isotretinoin—Urethral disorder—Etoposide—brain cancer	0.000107	0.000817	CcSEcCtD
Isotretinoin—Fatigue—Hydroxyurea—brain cancer	0.000107	0.000817	CcSEcCtD
Isotretinoin—Convulsion—Carmustine—brain cancer	0.000107	0.000813	CcSEcCtD
Isotretinoin—RARA—Generic Transcription Pathway—ESR2—brain cancer	0.000106	0.00316	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—ESR2—brain cancer	0.000106	0.00316	CbGpPWpGaD
Isotretinoin—Hypertension—Carmustine—brain cancer	0.000106	0.00081	CcSEcCtD
Isotretinoin—Pain—Hydroxyurea—brain cancer	0.000106	0.00081	CcSEcCtD
Isotretinoin—Constipation—Hydroxyurea—brain cancer	0.000106	0.00081	CcSEcCtD
Isotretinoin—Dizziness—Procarbazine—brain cancer	0.000106	0.00081	CcSEcCtD
Isotretinoin—RXRG—Adipogenesis—STAT3—brain cancer	0.000105	0.00312	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—NOTCH2—brain cancer	0.000105	0.00312	CbGpPWpGaD
Isotretinoin—Palpitations—Temozolomide—brain cancer	0.000105	0.000802	CcSEcCtD
Isotretinoin—Myalgia—Carmustine—brain cancer	0.000105	0.000799	CcSEcCtD
Isotretinoin—Chest pain—Carmustine—brain cancer	0.000105	0.000799	CcSEcCtD
Isotretinoin—Anxiety—Carmustine—brain cancer	0.000104	0.000796	CcSEcCtD
Isotretinoin—Cough—Temozolomide—brain cancer	0.000104	0.000791	CcSEcCtD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—RELA—brain cancer	0.000103	0.00307	CbGpPWpGaD
Isotretinoin—Erythema multiforme—Etoposide—brain cancer	0.000103	0.000788	CcSEcCtD
Isotretinoin—Convulsion—Temozolomide—brain cancer	0.000103	0.000786	CcSEcCtD
Isotretinoin—Hypertension—Temozolomide—brain cancer	0.000103	0.000783	CcSEcCtD
Isotretinoin—Feeling abnormal—Hydroxyurea—brain cancer	0.000102	0.000781	CcSEcCtD
Isotretinoin—Eye disorder—Etoposide—brain cancer	0.000102	0.000779	CcSEcCtD
Isotretinoin—Vomiting—Procarbazine—brain cancer	0.000102	0.000778	CcSEcCtD
Isotretinoin—Flushing—Etoposide—brain cancer	0.000101	0.000774	CcSEcCtD
Isotretinoin—Confusional state—Carmustine—brain cancer	0.000101	0.000772	CcSEcCtD
Isotretinoin—Myalgia—Temozolomide—brain cancer	0.000101	0.000772	CcSEcCtD
Isotretinoin—Arthralgia—Temozolomide—brain cancer	0.000101	0.000772	CcSEcCtD
Isotretinoin—Rash—Procarbazine—brain cancer	0.000101	0.000772	CcSEcCtD
Isotretinoin—Dermatitis—Procarbazine—brain cancer	0.000101	0.000771	CcSEcCtD
Isotretinoin—Anxiety—Temozolomide—brain cancer	0.000101	0.00077	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000101	0.00299	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—NOTCH2—brain cancer	0.000101	0.00299	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—NOTCH2—brain cancer	0.000101	0.00299	CbGpPWpGaD
Isotretinoin—Headache—Procarbazine—brain cancer	0.0001	0.000767	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.0001	0.000767	CcSEcCtD
Isotretinoin—Oedema—Carmustine—brain cancer	0.0001	0.000766	CcSEcCtD
Isotretinoin—Discomfort—Temozolomide—brain cancer	9.99e-05	0.000763	CcSEcCtD
Isotretinoin—Infection—Carmustine—brain cancer	9.97e-05	0.000761	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	9.94e-05	0.00295	CbGpPWpGaD
Isotretinoin—Angiopathy—Etoposide—brain cancer	9.91e-05	0.000756	CcSEcCtD
Isotretinoin—Dry mouth—Temozolomide—brain cancer	9.89e-05	0.000755	CcSEcCtD
Isotretinoin—RARA—Adipogenesis—STAT3—brain cancer	9.89e-05	0.00294	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—IRS2—brain cancer	9.86e-05	0.00293	CbGpPWpGaD
Isotretinoin—Thrombocytopenia—Carmustine—brain cancer	9.82e-05	0.00075	CcSEcCtD
Isotretinoin—Body temperature increased—Hydroxyurea—brain cancer	9.81e-05	0.000749	CcSEcCtD
Isotretinoin—Chills—Etoposide—brain cancer	9.8e-05	0.000748	CcSEcCtD
Isotretinoin—Tachycardia—Carmustine—brain cancer	9.79e-05	0.000748	CcSEcCtD
Isotretinoin—Confusional state—Temozolomide—brain cancer	9.78e-05	0.000746	CcSEcCtD
Isotretinoin—Anaphylactic shock—Temozolomide—brain cancer	9.7e-05	0.00074	CcSEcCtD
Isotretinoin—Oedema—Temozolomide—brain cancer	9.7e-05	0.00074	CcSEcCtD
Isotretinoin—Alopecia—Etoposide—brain cancer	9.65e-05	0.000737	CcSEcCtD
Isotretinoin—Infection—Temozolomide—brain cancer	9.63e-05	0.000735	CcSEcCtD
Isotretinoin—Anorexia—Carmustine—brain cancer	9.56e-05	0.00073	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	9.53e-05	0.00283	CbGpPWpGaD
Isotretinoin—Nausea—Procarbazine—brain cancer	9.53e-05	0.000727	CcSEcCtD
Isotretinoin—Nervous system disorder—Temozolomide—brain cancer	9.51e-05	0.000726	CcSEcCtD
Isotretinoin—Thrombocytopenia—Temozolomide—brain cancer	9.49e-05	0.000725	CcSEcCtD
Isotretinoin—Skin disorder—Temozolomide—brain cancer	9.42e-05	0.000719	CcSEcCtD
Isotretinoin—Hypotension—Carmustine—brain cancer	9.37e-05	0.000716	CcSEcCtD
Isotretinoin—Hyperhidrosis—Temozolomide—brain cancer	9.37e-05	0.000716	CcSEcCtD
Isotretinoin—Anorexia—Temozolomide—brain cancer	9.24e-05	0.000706	CcSEcCtD
Isotretinoin—Back pain—Etoposide—brain cancer	9.2e-05	0.000702	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	9.16e-05	0.00272	CbGpPWpGaD
Isotretinoin—Hypersensitivity—Hydroxyurea—brain cancer	9.14e-05	0.000698	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Carmustine—brain cancer	9.14e-05	0.000698	CcSEcCtD
Isotretinoin—Insomnia—Carmustine—brain cancer	9.07e-05	0.000693	CcSEcCtD
Isotretinoin—Paraesthesia—Carmustine—brain cancer	9.01e-05	0.000688	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	8.99e-05	0.00267	CbGpPWpGaD
Isotretinoin—Dyspnoea—Carmustine—brain cancer	8.94e-05	0.000683	CcSEcCtD
Isotretinoin—Somnolence—Carmustine—brain cancer	8.92e-05	0.000681	CcSEcCtD
Isotretinoin—Asthenia—Hydroxyurea—brain cancer	8.9e-05	0.00068	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	8.88e-05	0.00264	CbGpPWpGaD
Isotretinoin—Musculoskeletal discomfort—Temozolomide—brain cancer	8.83e-05	0.000674	CcSEcCtD
Isotretinoin—Ill-defined disorder—Etoposide—brain cancer	8.82e-05	0.000673	CcSEcCtD
Isotretinoin—Anaemia—Etoposide—brain cancer	8.79e-05	0.000671	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	8.78e-05	0.00261	CbGpPWpGaD
Isotretinoin—Insomnia—Temozolomide—brain cancer	8.77e-05	0.00067	CcSEcCtD
Isotretinoin—Decreased appetite—Carmustine—brain cancer	8.72e-05	0.000666	CcSEcCtD
Isotretinoin—Paraesthesia—Temozolomide—brain cancer	8.71e-05	0.000665	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	8.7e-05	0.00258	CbGpPWpGaD
Isotretinoin—Gastrointestinal disorder—Carmustine—brain cancer	8.66e-05	0.000661	CcSEcCtD
Isotretinoin—Dyspnoea—Temozolomide—brain cancer	8.64e-05	0.00066	CcSEcCtD
Isotretinoin—Somnolence—Temozolomide—brain cancer	8.62e-05	0.000658	CcSEcCtD
Isotretinoin—Constipation—Carmustine—brain cancer	8.58e-05	0.000655	CcSEcCtD
Isotretinoin—Pain—Carmustine—brain cancer	8.58e-05	0.000655	CcSEcCtD
Isotretinoin—Malaise—Etoposide—brain cancer	8.57e-05	0.000655	CcSEcCtD
Isotretinoin—Dyspepsia—Temozolomide—brain cancer	8.53e-05	0.000652	CcSEcCtD
Isotretinoin—Diarrhoea—Hydroxyurea—brain cancer	8.49e-05	0.000648	CcSEcCtD
Isotretinoin—Decreased appetite—Temozolomide—brain cancer	8.43e-05	0.000643	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	8.42e-05	0.0025	CbGpPWpGaD
Isotretinoin—Gastrointestinal disorder—Temozolomide—brain cancer	8.37e-05	0.000639	CcSEcCtD
Isotretinoin—Fatigue—Temozolomide—brain cancer	8.36e-05	0.000638	CcSEcCtD
Isotretinoin—Loss of consciousness—Etoposide—brain cancer	8.35e-05	0.000638	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	8.34e-05	0.00248	CbGpPWpGaD
Isotretinoin—Cough—Etoposide—brain cancer	8.3e-05	0.000633	CcSEcCtD
Isotretinoin—Pain—Temozolomide—brain cancer	8.29e-05	0.000633	CcSEcCtD
Isotretinoin—Constipation—Temozolomide—brain cancer	8.29e-05	0.000633	CcSEcCtD
Isotretinoin—Feeling abnormal—Carmustine—brain cancer	8.27e-05	0.000631	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	8.25e-05	0.00245	CbGpPWpGaD
Isotretinoin—Convulsion—Etoposide—brain cancer	8.24e-05	0.000629	CcSEcCtD
Isotretinoin—Hypertension—Etoposide—brain cancer	8.21e-05	0.000627	CcSEcCtD
Isotretinoin—Dizziness—Hydroxyurea—brain cancer	8.21e-05	0.000627	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Carmustine—brain cancer	8.2e-05	0.000626	CcSEcCtD
Isotretinoin—Chest pain—Etoposide—brain cancer	8.09e-05	0.000618	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	8.04e-05	0.000614	CcSEcCtD
Isotretinoin—Discomfort—Etoposide—brain cancer	8e-05	0.00061	CcSEcCtD
Isotretinoin—Feeling abnormal—Temozolomide—brain cancer	7.99e-05	0.00061	CcSEcCtD
Isotretinoin—Abdominal pain—Carmustine—brain cancer	7.93e-05	0.000606	CcSEcCtD
Isotretinoin—Body temperature increased—Carmustine—brain cancer	7.93e-05	0.000606	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Temozolomide—brain cancer	7.93e-05	0.000605	CcSEcCtD
Isotretinoin—Vomiting—Hydroxyurea—brain cancer	7.89e-05	0.000602	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	7.86e-05	0.00233	CbGpPWpGaD
Isotretinoin—Rash—Hydroxyurea—brain cancer	7.83e-05	0.000597	CcSEcCtD
Isotretinoin—Confusional state—Etoposide—brain cancer	7.82e-05	0.000597	CcSEcCtD
Isotretinoin—Dermatitis—Hydroxyurea—brain cancer	7.82e-05	0.000597	CcSEcCtD
Isotretinoin—Headache—Hydroxyurea—brain cancer	7.77e-05	0.000594	CcSEcCtD
Isotretinoin—Anaphylactic shock—Etoposide—brain cancer	7.76e-05	0.000592	CcSEcCtD
Isotretinoin—Infection—Etoposide—brain cancer	7.71e-05	0.000588	CcSEcCtD
Isotretinoin—Urticaria—Temozolomide—brain cancer	7.7e-05	0.000588	CcSEcCtD
Isotretinoin—Abdominal pain—Temozolomide—brain cancer	7.66e-05	0.000585	CcSEcCtD
Isotretinoin—Body temperature increased—Temozolomide—brain cancer	7.66e-05	0.000585	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	7.66e-05	0.00227	CbGpPWpGaD
Isotretinoin—Thrombocytopenia—Etoposide—brain cancer	7.6e-05	0.00058	CcSEcCtD
Isotretinoin—Tachycardia—Etoposide—brain cancer	7.57e-05	0.000578	CcSEcCtD
Isotretinoin—Skin disorder—Etoposide—brain cancer	7.54e-05	0.000575	CcSEcCtD
Isotretinoin—Hyperhidrosis—Etoposide—brain cancer	7.5e-05	0.000573	CcSEcCtD
Isotretinoin—Anorexia—Etoposide—brain cancer	7.4e-05	0.000565	CcSEcCtD
Isotretinoin—Hypersensitivity—Carmustine—brain cancer	7.39e-05	0.000564	CcSEcCtD
Isotretinoin—Nausea—Hydroxyurea—brain cancer	7.37e-05	0.000563	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—IDH1—brain cancer	7.37e-05	0.00219	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	7.34e-05	0.00218	CbGpPWpGaD
Isotretinoin—Hypotension—Etoposide—brain cancer	7.25e-05	0.000553	CcSEcCtD
Isotretinoin—Asthenia—Carmustine—brain cancer	7.2e-05	0.00055	CcSEcCtD
Isotretinoin—Hypersensitivity—Temozolomide—brain cancer	7.14e-05	0.000545	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	7.05e-05	0.00209	CbGpPWpGaD
Isotretinoin—Paraesthesia—Etoposide—brain cancer	6.97e-05	0.000532	CcSEcCtD
Isotretinoin—Asthenia—Temozolomide—brain cancer	6.96e-05	0.000531	CcSEcCtD
Isotretinoin—Dyspnoea—Etoposide—brain cancer	6.92e-05	0.000528	CcSEcCtD
Isotretinoin—Somnolence—Etoposide—brain cancer	6.9e-05	0.000527	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	6.89e-05	0.00205	CbGpPWpGaD
Isotretinoin—Diarrhoea—Carmustine—brain cancer	6.86e-05	0.000524	CcSEcCtD
Isotretinoin—Pruritus—Temozolomide—brain cancer	6.86e-05	0.000524	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	6.8e-05	0.00202	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	6.76e-05	0.00201	CbGpPWpGaD
Isotretinoin—Decreased appetite—Etoposide—brain cancer	6.74e-05	0.000515	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Etoposide—brain cancer	6.7e-05	0.000511	CcSEcCtD
Isotretinoin—Fatigue—Etoposide—brain cancer	6.69e-05	0.000511	CcSEcCtD
Isotretinoin—Dizziness—Carmustine—brain cancer	6.63e-05	0.000507	CcSEcCtD
Isotretinoin—Pain—Etoposide—brain cancer	6.63e-05	0.000507	CcSEcCtD
Isotretinoin—Constipation—Etoposide—brain cancer	6.63e-05	0.000507	CcSEcCtD
Isotretinoin—RARG—Gene Expression—DNMT1—brain cancer	6.63e-05	0.00197	CbGpPWpGaD
Isotretinoin—Diarrhoea—Temozolomide—brain cancer	6.63e-05	0.000506	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	6.61e-05	0.00196	CbGpPWpGaD
Isotretinoin—Dizziness—Temozolomide—brain cancer	6.41e-05	0.00049	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—APC—brain cancer	6.4e-05	0.0019	CbGpPWpGaD
Isotretinoin—Feeling abnormal—Etoposide—brain cancer	6.39e-05	0.000488	CcSEcCtD
Isotretinoin—Vomiting—Carmustine—brain cancer	6.38e-05	0.000487	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Etoposide—brain cancer	6.34e-05	0.000484	CcSEcCtD
Isotretinoin—Rash—Carmustine—brain cancer	6.33e-05	0.000483	CcSEcCtD
Isotretinoin—Dermatitis—Carmustine—brain cancer	6.32e-05	0.000483	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—TRPC6—brain cancer	6.29e-05	0.00187	CbGpPWpGaD
Isotretinoin—Headache—Carmustine—brain cancer	6.29e-05	0.00048	CcSEcCtD
Isotretinoin—Vomiting—Temozolomide—brain cancer	6.16e-05	0.000471	CcSEcCtD
Isotretinoin—Urticaria—Etoposide—brain cancer	6.16e-05	0.000471	CcSEcCtD
Isotretinoin—Abdominal pain—Etoposide—brain cancer	6.13e-05	0.000468	CcSEcCtD
Isotretinoin—Body temperature increased—Etoposide—brain cancer	6.13e-05	0.000468	CcSEcCtD
Isotretinoin—Rash—Temozolomide—brain cancer	6.11e-05	0.000467	CcSEcCtD
Isotretinoin—Dermatitis—Temozolomide—brain cancer	6.11e-05	0.000466	CcSEcCtD
Isotretinoin—Headache—Temozolomide—brain cancer	6.07e-05	0.000464	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—DNMT1—brain cancer	6.07e-05	0.0018	CbGpPWpGaD
Isotretinoin—Nausea—Carmustine—brain cancer	5.96e-05	0.000455	CcSEcCtD
Isotretinoin—RARG—Gene Expression—ESR2—brain cancer	5.96e-05	0.00177	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—DNMT1—brain cancer	5.95e-05	0.00177	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—CTNNB1—brain cancer	5.91e-05	0.00176	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	5.79e-05	0.00172	CbGpPWpGaD
Isotretinoin—Nausea—Temozolomide—brain cancer	5.76e-05	0.00044	CcSEcCtD
Isotretinoin—Hypersensitivity—Etoposide—brain cancer	5.72e-05	0.000436	CcSEcCtD
Isotretinoin—RARA—Gene Expression—DNMT1—brain cancer	5.7e-05	0.00169	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—DNMT1—brain cancer	5.7e-05	0.00169	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—NOTCH2—brain cancer	5.64e-05	0.00168	CbGpPWpGaD
Isotretinoin—Asthenia—Etoposide—brain cancer	5.57e-05	0.000425	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	5.55e-05	0.00165	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—ESR2—brain cancer	5.54e-05	0.00165	CbGpPWpGaD
Isotretinoin—Pruritus—Etoposide—brain cancer	5.49e-05	0.000419	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—ESR2—brain cancer	5.45e-05	0.00162	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—ESR2—brain cancer	5.34e-05	0.00159	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—TRPC6—brain cancer	5.34e-05	0.00159	CbGpPWpGaD
Isotretinoin—Diarrhoea—Etoposide—brain cancer	5.31e-05	0.000405	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—NOTCH2—brain cancer	5.25e-05	0.00156	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—NOTCH2—brain cancer	5.16e-05	0.00153	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—STAT3—brain cancer	5.15e-05	0.00153	CbGpPWpGaD
Isotretinoin—Dizziness—Etoposide—brain cancer	5.13e-05	0.000392	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—ESR2—brain cancer	5.12e-05	0.00152	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—ESR2—brain cancer	5.12e-05	0.00152	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—NOTCH2—brain cancer	5.06e-05	0.0015	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	4.97e-05	0.00148	CbGpPWpGaD
Isotretinoin—Vomiting—Etoposide—brain cancer	4.93e-05	0.000377	CcSEcCtD
Isotretinoin—Rash—Etoposide—brain cancer	4.89e-05	0.000373	CcSEcCtD
Isotretinoin—Dermatitis—Etoposide—brain cancer	4.89e-05	0.000373	CcSEcCtD
Isotretinoin—Headache—Etoposide—brain cancer	4.86e-05	0.000371	CcSEcCtD
Isotretinoin—RARA—Gene Expression—NOTCH2—brain cancer	4.85e-05	0.00144	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—NOTCH2—brain cancer	4.85e-05	0.00144	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—SIRT1—brain cancer	4.8e-05	0.00142	CbGpPWpGaD
Isotretinoin—Nausea—Etoposide—brain cancer	4.61e-05	0.000352	CcSEcCtD
Isotretinoin—RXRA—Metabolism—CYP2C9—brain cancer	4.49e-05	0.00133	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	4.39e-05	0.0013	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—SIRT1—brain cancer	4.39e-05	0.0013	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	4.35e-05	0.00129	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—SIRT1—brain cancer	4.3e-05	0.00128	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—SIRT1—brain cancer	4.12e-05	0.00122	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—SIRT1—brain cancer	4.12e-05	0.00122	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—HES1—brain cancer	4.05e-05	0.0012	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—MYC—brain cancer	3.9e-05	0.00116	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	3.83e-05	0.00114	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—BSG—brain cancer	3.82e-05	0.00113	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—MYC—brain cancer	3.57e-05	0.00106	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	3.52e-05	0.00105	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—MYC—brain cancer	3.5e-05	0.00104	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	3.44e-05	0.00102	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—MYC—brain cancer	3.36e-05	0.000996	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—MYC—brain cancer	3.36e-05	0.000996	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—IDH1—brain cancer	3.28e-05	0.000974	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—CDK4—brain cancer	3.18e-05	0.000944	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—DNMT1—brain cancer	2.97e-05	0.000883	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.89e-05	0.000859	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.67e-05	0.000793	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—ESR2—brain cancer	2.67e-05	0.000793	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ENO2—brain cancer	2.59e-05	0.00077	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NOTCH2—brain cancer	2.53e-05	0.000751	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—RELA—brain cancer	2.34e-05	0.000694	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—ERBB2—brain cancer	2.32e-05	0.00069	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—SIRT1—brain cancer	2.15e-05	0.000638	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—CTNNB1—brain cancer	2.03e-05	0.000604	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—MYC—brain cancer	1.88e-05	0.000558	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—VEGFA—brain cancer	1.79e-05	0.000531	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—STAT3—brain cancer	1.77e-05	0.000526	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—MYC—brain cancer	1.75e-05	0.000519	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—MYC—brain cancer	1.72e-05	0.00051	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—MYC—brain cancer	1.69e-05	0.0005	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—MYC—brain cancer	1.62e-05	0.00048	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—MYC—brain cancer	1.62e-05	0.00048	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—EGFR—brain cancer	1.61e-05	0.000478	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3CG—brain cancer	1.19e-05	0.000353	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—MYC—brain cancer	8.42e-06	0.00025	CbGpPWpGaD
